Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;22(4):524-542.
doi: 10.2174/1570159X21666230807152051.

Inflammation in Posttraumatic Stress Disorder: Dysregulation or Recalibration?

Kostas Patas  1 , Dewleen G Baker  2   3 , George P Chrousos  4 , Agorastos Agorastos  3   5
Affiliations

Inflammation in Posttraumatic Stress Disorder: Dysregulation or Recalibration?

Kostas Patas et al. Curr Neuropharmacol. 2024.

Abstract

Despite ample experimental data indicating a role of inflammatory mediators in the behavioral and neurobiological manifestations elicited by exposure to physical and psychologic stressors, causative associations between systemic low-grade inflammation and central nervous system inflammatory processes in posttraumatic stress disorder (PTSD) patients remain largely conceptual. As in other stress-related disorders, pro-inflammatory activity may play an equivocal role in PTSD pathophysiology, one that renders indiscriminate employment of anti-inflammatory agents of questionable relevance. In fact, as several pieces of preclinical and clinical research convergingly suggest, timely and targeted potentiation rather than inhibition of inflammatory responses may actually be beneficial in patients who are characterized by suppressed microglia function in the face of systemic low-grade inflammation. The deleterious impact of chronic stress-associated inflammation on the systemic level may, thus, need to be held in context with the - often not readily apparent - adaptive payoffs of low-grade inflammation at the tissue level.

Keywords: Posttraumatic stress disorder (PTSD); anti-inflammatory agents.; immune system; inflammation; microglia; neurobiology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest, financial or otherwise.

Figures

Fig. (1)
Fig. (1)
Proposed model represents the dynamic alterations in systemic inflammation and microglia activation status in PTSD based on the type of response in the periphery (A) and within the CNS (B). Non-resolving, low-grade inflammation in the chronic post-trauma phase may be associated with either an excessive or a subnormal inflammatory response in the acute post-trauma phase in both compartments. However, an excessive or subnormal CNS inflammatory response in the acute phase may also pave the way to a premature suppression of microglia activity. Accordingly, both anti-inflammatory approaches (acutely and subacutely post-trauma) and pro-inflammatory approaches (in the form of either pre-trauma immunization or post-trauma boosters) may be therapeutically pertinent, depending on whether the microglia compartment is in a state of overactivation or suppression, respectively.
Fig. (2)
Fig. (2)
Potential therapeutic and/or prophylactic immunostimulatory approaches leading to enhanced stress resilience. References are provided in the text. Abbreviations: LPS: lipopolysaccharide; CNS: central nervous system; Treg: regulatory T cells; GC: glucocorticoid.
See this image and copyright information in PMC

References

    1. Benjet C., Bromet E., Karam E.G., Kessler R.C., McLaughlin K.A., Ruscio A.M., Shahly V., Stein D.J., Petukhova M., Hill E., Alonso J., Atwoli L., Bunting B., Bruffaerts R., Caldas-de-Almeida J.M., de Girolamo G., Florescu S., Gureje O., Huang Y., Lepine J.P., Kawakami N., Kovess-Masfety V., Medina-Mora M.E., Navarro-Mateu F., Piazza M., Posada-Villa J., Scott K.M., Shalev A., Slade T., ten Have M., Torres Y., Viana M.C., Zarkov Z., Koenen K.C. The epidemiology of traumatic event exposure worldwide: Results from the World Mental Health Survey Consortium. Psychol. Med. 2016;46(2):327–343. doi: 10.1017/S0033291715001981. - DOI - PMC - PubMed
    1. Koenen K.C., Ratanatharathorn A., Ng L., McLaughlin K.A., Bromet E.J., Stein D.J., Karam E.G., Meron Ruscio A., Benjet C., Scott K., Atwoli L., Petukhova M., Lim C.C.W., Aguilar-Gaxiola S., Al-Hamzawi A., Alonso J., Bunting B., Ciutan M., de Girolamo G., Degenhardt L., Gureje O., Haro J.M., Huang Y., Kawakami N., Lee S., Navarro-Mateu F., Pennell B.E., Piazza M., Sampson N., ten Have M., Torres Y., Viana M.C., Williams D., Xavier M., Kessler R.C. Posttraumatic stress disorder in the World Mental Health Surveys. Psychol. Med. 2017;47(13):2260–2274. doi: 10.1017/S0033291717000708. - DOI - PMC - PubMed
    1. Murrough J.W., Russo S.J. The neurobiology of resilience: Complexity and hope. Biol. Psychiatry. 2019;86(6):406–409. doi: 10.1016/j.biopsych.2019.07.016. - DOI - PubMed
    1. Hodes G.E., Epperson C.N. Sex differences in vulnerability and resilience to stress across the life span. Biol. Psychiatry. 2019;86(6):421–432. doi: 10.1016/j.biopsych.2019.04.028. - DOI - PMC - PubMed
    1. Agorastos A., Pervanidou P., Chrousos G.P., Baker D.G. Developmental trajectories of early life stress and trauma: A narrative review on neurobiological aspects beyond stress system dysregulation. Front. Psychiatry. 2019;10:118. doi: 10.3389/fpsyt.2019.00118. - DOI - PMC - PubMed